Advanced Search
Contact | Corporate | Help

Best Promising Drug Association With Azacitidine in Higher Risk Myelodysplastic Syndromes

Sponsors:
  • Assistance Publique - Hôpitaux de Paris
Phases:
  • Phase II
IndicationsAcronym:
AZA-PLUS
  • MDS
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Azacitidine
  • Drug: Azacitidine associated with Valproic acid
  • Drug: Azacitidine associated with Lenalidomide
Enrollment:
240

Additional information about NCT01342692.


SourceSolution © 2008-2012